Elevated Triglyceride Levels and Later Type 2 Diabetes
This study has been completed.
Sponsor:
University of Tromso
Information provided by:
University of Tromso
ClinicalTrials.gov Identifier:
NCT01182935
First received: August 11, 2010
Last updated: July 19, 2011
Last verified: July 2011
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | August 11, 2010 | ||||
| Last Updated Date | July 19, 2011 | ||||
| Start Date ICMJE | April 2010 | ||||
| Primary Completion Date | September 2010 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Number of subjects with type 2 diabetes diagnosed with oral glucose tolerance test (OGTT) [ Time Frame: At study enrollment in 2010 ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT01182935 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
The relation between serum 25(OH)D levels and blood glucose levels at OGTT [ Time Frame: At study enrollment in 2010 ] [ Designated as safety issue: No ] | ||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Elevated Triglyceride Levels and Later Type 2 Diabetes | ||||
| Official Title ICMJE | Elevated Triglyceride Levels and Later Type 2 Diabetes | ||||
| Brief Summary | Subjects with elevated serum triglycerides in the 4th Tromso study in 1994/1995 were re-examined with an oral glucose tolerance test to see predictive value of triglycerides regarding development of type 2 diabetes |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Cohort Time Perspective: Prospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Retention: Samples Without DNA Description: serum |
||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | participants in the 4 Tromsø study 1994 and with elevated serum triglyceride levels |
||||
| Condition ICMJE | Type 2 Diabetes | ||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) | participants in the 4th Tromsø study | ||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 3509 | ||||
| Completion Date | November 2010 | ||||
| Primary Completion Date | September 2010 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 20 Years to 80 Years | ||||
| Accepts Healthy Volunteers | Yes | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | Norway | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01182935 | ||||
| Other Study ID Numbers ICMJE | UIT-ENDO-2010-3 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Rolf Jorde, Univesity of Tromsø | ||||
| Study Sponsor ICMJE | University of Tromso | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | University of Tromso | ||||
| Verification Date | July 2011 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||